Showing results (161-170 of 425) with videos related to
Sort By:
Pageof 43
Research in Developmental Disabilities|July 10, 2021
Sleep quality, functional skills, and communication in preschool-aged children with autism spectrum disorderDionísia Aparecida Cusin Lamônica, Celia Maria Giacheti, Michele Dias Hayssi Haduo, et al.Brain Research|October 29, 2013
Intrinsic organization of the suprachiasmatic nucleus in the capuchin monkeyV A Rocha, R Frazão, L M G Campos, et al.Cancer|June 21, 2022
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trialAlessio Cortellini, Biagio Ricciuti, Hossein Borghaei, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 14, 2015
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinomaCarlo Smirne, Glenda Grossi, David J Pinato, et al.Cancer Epidemiology|May 25, 2025
Impact of GLP-1 receptor agonist-induced weight loss on 22 cancers in the next ten years using a Markov state-transition model - A UK weight and wellness cancer landscape analysisJiawen Dong, Thomas Starkey, Vinton W T Cheng, et al.Nature Reviews. Clinical Oncology|November 12, 2021
Immunotherapies for hepatocellular carcinomaJosep M Llovet, Florian Castet, Mathias Heikenwalder, et al.Immunotherapy|April 5, 2019
PD-L1 expressing granulomatous reaction as an on-target mechanism of steroid-refractory immune hepatotoxicityJames Rm Black, Robert D Goldin, Matthew Foxton, et al.Neuroscience Letters|September 4, 2018
Day/night melatonin content in cerebral palsyJanaina S Santos, Celia M Giacheti, Lilian S Dornelas, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 11, 2023
A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLCMitchell Chen, Haonan Lu, Susan J Copley, et al.Current Oncology Reports|December 23, 2025
Host-related Determinants of Response to Immunotherapy in Non-small Cell Lung Cancer: The Interplay of Body Composition, Metabolism, Sex and Immune RegulationValentina Santo, Leonardo Brunetti, Federica Pecci, et al.Pageof 43